NG2‐glia abnormalities and microglia activation are involved in the development and/or progression of neurodegenerative disorders, such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, and cerebrovascular diseases. The gene discussed is CSPG4; the disease is early-onset autosomal dominant Alzheimer disease.